Monograph Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
9
- Investments
-
22
- Portfolio
-
12
- Exits
-
4
Monograph Capital General Information
Company Description
Founded in 2021, Monograph Capital is a venture capital investment firm headquartered in San Francisco and London. The firm invests in life sciences companies that seek to create new or improved therapeutics and related technology-enabled service businesses.
Business Details
Website
www.monograph.bioYear Founded
Investor Status
Primary Investor Type
Corporate Office
- Liberty House
- 222 Regent Street
- London W1B 5TR
- England, United Kingdom
Monograph Capital Investments (22)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| RQ Bio | 04-Jun-2026 | Later Stage VC | Biotechnology | Generating Revenue | ||
| Nocion Therapeutics | 07-Jan-2026 | Drug Discovery | Clinical Trials - Phase 2 | |||
| ProLynx | 11-Dec-2025 | Drug Delivery | Generating Revenue | |||
| Elevara Medicines | 22-Oct-2025 | Therapeutic Devices | Clinical Trials - Phase 2 | |||
| Ollin | 17-Sep-2025 | Drug Discovery | Clinical Trials - Phase 3 | |||
| Ouro Medicines | 08-Jul-2025 | Drug Discovery | Generating Revenue | |||
| Maxion Therapeutics | 15-Feb-2025 | Drug Discovery | Generating Revenue | |||
| Ascend (Drug Discovery) | 12-Nov-2024 | Drug Discovery | Generating Revenue | |||
| AviadoBio | 08-Oct-2024 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 | ||
| Autobahn Therapeutics | 24-Jul-2024 | Later Stage VC | Biotechnology | Clinical Trials - Phase 2 |
Monograph Capital Exits (4)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Ouro Medicines | 01-Jun-2026 | Merger/Acquisition | |
| HI-Bio | 02-Jul-2024 | ||
| Urogen Pharma | 17-Jun-2024 | Public Investment 2nd Offering | |
| MiroBio | 20-Sep-2022 | Merger/Acquisition |
Monograph Capital Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
Monograph Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Monograph Capital Co-Investors (87)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| ARCH Venture Partners | 3 |
|
|
||
| LifeArc Ventures |
|
|
|||
| Canaan Partners |
|
|
|||
| Forbion |
|
|
|||
| TPG |
|
|
Monograph Capital FAQs
-
What is Monograph Capital?
Founded in 2021, Monograph Capital is a venture capital investment firm headquartered in San Francisco and London.
-
When was Monograph Capital founded?
Monograph Capital was founded in 2021.
-
Where is Monograph Capital headquartered?
Monograph Capital is headquartered in London, United Kingdom.
-
How many investments has Monograph Capital made?
Monograph Capital has made 22 investments.
-
What has Monograph Capital invested in?
Monograph Capital has made numerous investments in companies like RQ Bio, Nocion Therapeutics, and ProLynx within the Biotechnology, Drug Discovery, and Drug Delivery industries.
-
What has Monograph Capital invested in recently?
Monograph Capital's latest investment was on 04-Jun-2026 in RQ Bio, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
